Trial Profile
Randomized trial comparing valacyclovir versus valganciclovir prophylaxis of cytomegalovirus infection in renal transplant recipients
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 16 Jan 2019
Price :
$35
*
At a glance
- Drugs Valaciclovir (Primary) ; Valganciclovir (Primary)
- Indications Cytomegalic inclusion disorders; Cytomegalovirus infections
- Focus Biomarker; Therapeutic Use
- Acronyms 2VAL
- 11 Jul 2011 New trial record